Bornholm disease future or investigational therapies: Difference between revisions
No edit summary |
No edit summary |
||
| Line 2: | Line 2: | ||
{{Bornholm disease}} | {{Bornholm disease}} | ||
{{CMG}}; '''Associate Editor(s)-in-Chief:''' Arooj Naz | |||
<br /> | |||
== Overview == | |||
The prevention of [[Bornholm disease]] focuses on preventing infections with [[Coxsackie virus|Coxsackie]] virus, as it is the most common underlying cause. The Coxsackie virus can persist for prolonged durations. The Coxsackie virus is an [[RNA]] virus that is non-enveloped, positive single stranded and has the ability to form an envelope by taking over host membranes which provides resistance. The relationship between Coxsackie viral infections and chronic disease is also of interest, especially [[autoimmune]] conditions. These include [[chronic myocarditis]], [[diabetes]] and chronic [[inflammatory myopathy]]. Apart from studying the relationship between coxsackie virus and chronic conditions, the effects in utero are also being studied. [[Neonates]] may present with fetal [[myocarditis]] and [[Neurodevelopmental disorders|neurodevelopmental]] delays, possibly due to [[meningitis]] and [[encephalitis]]. | |||
== Future or Investigational therapies == | |||
To understand prevention, it is important to first understand the properties of the virus. [[Coxsackie virus|Coxsackie]] virus is:<ref name="pmid26142496">{{cite journal| author=Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R| title=Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis. | journal=Virology | year= 2015 | volume= 484 | issue= | pages= 288-304 | pmid=26142496 | doi=10.1016/j.virol.2015.06.006 | pmc=4567421 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=26142496 }}</ref> | |||
* non-enveloped; which allows it to survive in harsh environments | |||
* [[RNA]] virus | |||
* positive single stranded | |||
* ability to form an envelope by taking over host membranes; provides resistance | |||
Currently, studied are being done to understand the relationship between [[Coxsackie virus|Coxsackie]] virus and in utero infections. [[Newborns]] may present with [[Myocarditis|fetal myocarditis]] and [[Neurodevelopmental disorders|neurodevelopmental]] delays, possibly due to [[meningitis]] and [[encephalitis]]. The risk of [[spontaneous abortions]] is also higher, and the [[mortality rate]] is around 10%.<ref name="pmid16480851">{{cite journal| author=Ornoy A, Tenenbaum A| title=Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses. | journal=Reprod Toxicol | year= 2006 | volume= 21 | issue= 4 | pages= 446-57 | pmid=16480851 | doi=10.1016/j.reprotox.2005.12.007 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16480851 }}</ref> | |||
As the disease presents in the form of [[epidemics]] and affects masses of individuals at once, vaccinations are also being studied. Due to the genetic variability and various disease possibilities, this process remains a challenge. | |||
The relationship between [[Coxsackie virus|Coxsackie]] viral infections and chronic disease is also of interest, especially autoimmune conditions. These include [[chronic myocarditis]], [[diabetes]] and [[Inflammatory myopathy|chronic inflammatory myopathy]].<ref name="pmid9662368">{{cite journal| author=Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N| title=Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. | journal=Nat Med | year= 1998 | volume= 4 | issue= 7 | pages= 781-5 | pmid=9662368 | doi=10.1038/nm0798-781 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9662368 }}</ref> | |||
==References== | ==References== | ||
Revision as of 06:07, 23 February 2022
|
Bornholm disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Bornholm disease future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Bornholm disease future or investigational therapies |
|
Bornholm disease future or investigational therapies in the news |
|
Blogs on Bornholm disease future or investigational therapies |
|
Risk calculators and risk factors for Bornholm disease future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Arooj Naz
Overview
The prevention of Bornholm disease focuses on preventing infections with Coxsackie virus, as it is the most common underlying cause. The Coxsackie virus can persist for prolonged durations. The Coxsackie virus is an RNA virus that is non-enveloped, positive single stranded and has the ability to form an envelope by taking over host membranes which provides resistance. The relationship between Coxsackie viral infections and chronic disease is also of interest, especially autoimmune conditions. These include chronic myocarditis, diabetes and chronic inflammatory myopathy. Apart from studying the relationship between coxsackie virus and chronic conditions, the effects in utero are also being studied. Neonates may present with fetal myocarditis and neurodevelopmental delays, possibly due to meningitis and encephalitis.
Future or Investigational therapies
To understand prevention, it is important to first understand the properties of the virus. Coxsackie virus is:[1]
- non-enveloped; which allows it to survive in harsh environments
- RNA virus
- positive single stranded
- ability to form an envelope by taking over host membranes; provides resistance
Currently, studied are being done to understand the relationship between Coxsackie virus and in utero infections. Newborns may present with fetal myocarditis and neurodevelopmental delays, possibly due to meningitis and encephalitis. The risk of spontaneous abortions is also higher, and the mortality rate is around 10%.[2]
As the disease presents in the form of epidemics and affects masses of individuals at once, vaccinations are also being studied. Due to the genetic variability and various disease possibilities, this process remains a challenge.
The relationship between Coxsackie viral infections and chronic disease is also of interest, especially autoimmune conditions. These include chronic myocarditis, diabetes and chronic inflammatory myopathy.[3]
References
- ↑ Sin J, Mangale V, Thienphrapa W, Gottlieb RA, Feuer R (2015). "Recent progress in understanding coxsackievirus replication, dissemination, and pathogenesis". Virology. 484: 288–304. doi:10.1016/j.virol.2015.06.006. PMC 4567421. PMID 26142496.
- ↑ Ornoy A, Tenenbaum A (2006). "Pregnancy outcome following infections by coxsackie, echo, measles, mumps, hepatitis, polio and encephalitis viruses". Reprod Toxicol. 21 (4): 446–57. doi:10.1016/j.reprotox.2005.12.007. PMID 16480851.
- ↑ Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J, Sarvetnick N (1998). "Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry". Nat Med. 4 (7): 781–5. doi:10.1038/nm0798-781. PMID 9662368.